During the past decade, Georgia Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 12 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Georgia Clinical Research" #1 sponsor was "Astellas Pharma Global Development, Inc." with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "Neurana Pharmaceuticals, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Georgia Clinical Research" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Georgia Clinical Research" are "Diabetes Mellitus, Type 2" (3 trials), "Acute Pain" (2 trials), "Back Pain" (2 trials), "Back Strain" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Georgia Clinical Research" in a lesser frequency.

Most popular intervention types in "Georgia Clinical Research" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "placebo" (3 trials), "Elobixibat 10 mg" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "linagliptin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Georgia Clinical Research" are 13 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Georgia Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Georgia Clinical Research, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Georgia Clinical Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".